Current Status of Bill S 4302
Bill S 4302 is currently in the status of Bill Introduced since May 25, 2022. Bill S 4302 was introduced during Congress 117 and was introduced to the Senate on May 25, 2022. Bill S 4302's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709) as of May 25, 2022
Bipartisan Support of Bill S 4302
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
3Democrat Cosponsors
1Republican Cosponsors
2Unaffiliated Cosponsors
0
Policy Area and Potential Impact of Bill S 4302
Primary Policy Focus
Health
Alternate Title(s) of Bill S 4302
Biologics Market Transparency Act of 2022Biologics Market Transparency Act of 2022A bill to amend the Federal Food, Drug, and Cosmetic Act to require prompt reports of marketing status by holders of approved applications for biological products, and for other purposes.